Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 128

1.

Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma.

Marin JJG, Macias RIR, Cives-Losada C, Peleteiro-Vigil A, Herraez E, Lozano E.

Cells. 2020 Feb 21;9(2). pii: E498. doi: 10.3390/cells9020498. Review.

PMID:
32098199
2.

Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinoma.

Soto M, Reviejo M, Al-Abdulla R, Romero MR, Macias RIR, Boix L, Bruix J, Serrano MA, Marin JJG.

Biochim Biophys Acta Mol Basis Dis. 2020 Jan 15;1866(5):165687. doi: 10.1016/j.bbadis.2020.165687. [Epub ahead of print]

PMID:
31953214
3.

MRP3-mediated chemoresistance in cholangiocarcinoma: Target for chemosensitization through restoring SOX17 expression.

Lozano E, Asensio M, Perez-Silva L, Banales JM, Briz O, Marin JJG.

Hepatology. 2019 Dec 20. doi: 10.1002/hep.31088. [Epub ahead of print]

PMID:
31863486
4.

Models for Understanding Resistance to Chemotherapy in Liver Cancer.

Marin JJG, Herraez E, Lozano E, Macias RIR, Briz O.

Cancers (Basel). 2019 Oct 29;11(11). pii: E1677. doi: 10.3390/cancers11111677. Review.

5.

Sensitizing gastric adenocarcinoma to chemotherapy by pharmacological manipulation of drug transporters.

Al-Abdulla R, Perez-Silva L, Lozano E, Macias RIR, Herraez E, Abad M, Segues N, Bujanda L, Briz O, Marin JJG.

Biochem Pharmacol. 2020 Jan;171:113682. doi: 10.1016/j.bcp.2019.113682. Epub 2019 Oct 24.

PMID:
31669256
6.

Hepatoprotection of Mentha aquatica L., Lavandula dentata L. and Leonurus cardiaca L.

Pereira OR, Macias RIR, Domingues MRM, Marin JJG, Cardoso SM.

Antioxidants (Basel). 2019 Aug 2;8(8). pii: E267. doi: 10.3390/antiox8080267.

7.

Leishmania heme uptake involves LmFLVCRb, a novel porphyrin transporter essential for the parasite.

Cabello-Donayre M, Orrego LM, Herráez E, Vargas P, Martínez-García M, Campos-Salinas J, Pérez-Victoria I, Vicente B, Marín JJG, Pérez-Victoria JM.

Cell Mol Life Sci. 2019 Aug 1. doi: 10.1007/s00018-019-03258-3. [Epub ahead of print]

PMID:
31372684
8.

What "The Cancer Genome Atlas" database tells us about the role of ATP-binding cassette (ABC) proteins in chemoresistance to anticancer drugs.

Briz O, Perez-Silva L, Al-Abdulla R, Abete L, Reviejo M, Romero MR, Marin JJG.

Expert Opin Drug Metab Toxicol. 2019 Jul;15(7):577-593. doi: 10.1080/17425255.2019.1631285. Epub 2019 Jun 23. Review.

PMID:
31185182
9.

Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy.

Lozano E, Macias RIR, Monte MJ, Asensio M, Del Carmen S, Sanchez-Vicente L, Alonso-Peña M, Al-Abdulla R, Munoz-Garrido P, Satriano L, O'Rourke CJ, Banales JM, Avila MA, Martinez-Chantar ML, Andersen JB, Briz O, Marin JJG.

Hepatology. 2019 Oct;70(4):1246-1261. doi: 10.1002/hep.30656. Epub 2019 May 20.

PMID:
30972782
10.

Evaluation of the promiscuous component of several bacterial export pumps TolC as a biomarker for toxic pollutants in feedstuffs.

Perez-Silva L, Sanchez-Vicente L, Molina-Alcaide E, Marin JJG, Herraez E.

Chem Biol Interact. 2019 May 25;305:195-202. doi: 10.1016/j.cbi.2019.03.028. Epub 2019 Mar 30.

PMID:
30940451
11.

Mechanisms of Anticancer Drug Resistance in Hepatoblastoma.

Marin JJG, Cives-Losada C, Asensio M, Lozano E, Briz O, Macias RIR.

Cancers (Basel). 2019 Mar 22;11(3). pii: E407. doi: 10.3390/cancers11030407. Review.

12.

Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance.

Fouassier L, Marzioni M, Afonso MB, Dooley S, Gaston K, Giannelli G, Rodrigues CMP, Lozano E, Mancarella S, Segatto O, Vaquero J, Marin JJG, Coulouarn C.

Liver Int. 2019 May;39 Suppl 1:43-62. doi: 10.1111/liv.14102. Review.

13.

Unraveling 'The Cancer Genome Atlas' information on the role of SLC transporters in anticancer drug uptake.

Al-Abdulla R, Perez-Silva L, Abete L, Romero MR, Briz O, Marin JJG.

Expert Rev Clin Pharmacol. 2019 Apr;12(4):329-341. doi: 10.1080/17512433.2019.1581605. Epub 2019 Feb 26. Review.

PMID:
30744443
14.

Chemosensitization of hepatocellular carcinoma cells to sorafenib by β-caryophyllene oxide-induced inhibition of ABC export pumps.

Di Giacomo S, Briz O, Monte MJ, Sanchez-Vicente L, Abete L, Lozano E, Mazzanti G, Di Sotto A, Marin JJG.

Arch Toxicol. 2019 Mar;93(3):623-634. doi: 10.1007/s00204-019-02395-9. Epub 2019 Jan 18.

PMID:
30659321
15.

Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib.

Al-Abdulla R, Lozano E, Macias RIR, Monte MJ, Briz O, O'Rourke CJ, Serrano MA, Banales JM, Avila MA, Martinez-Chantar ML, Geier A, Andersen JB, Marin JJG.

Br J Pharmacol. 2019 Mar;176(6):787-800. doi: 10.1111/bph.14563. Epub 2019 Feb 11.

PMID:
30592786
16.

Wnt-β-catenin signalling in liver development, health and disease.

Perugorria MJ, Olaizola P, Labiano I, Esparza-Baquer A, Marzioni M, Marin JJG, Bujanda L, Banales JM.

Nat Rev Gastroenterol Hepatol. 2019 Feb;16(2):121-136. doi: 10.1038/s41575-018-0075-9. Review.

PMID:
30451972
17.

The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis.

Santamaría E, Rodríguez-Ortigosa CM, Uriarte I, Latasa MU, Urtasun R, Alvarez-Sola G, Bárcena-Varela M, Colyn L, Arcelus S, Jiménez M, Deutschmann K, Peleteiro-Vigil A, Gómez-Cambronero J, Milkiewicz M, Milkiewicz P, Sangro B, Keitel V, Monte MJ, Marin JJG, Fernández-Barrena MG, Ávila MA, Berasain C.

Hepatology. 2019 Apr;69(4):1632-1647. doi: 10.1002/hep.30348. Epub 2019 Mar 4.

PMID:
30411380
18.

Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.

Banales JM, Iñarrairaegui M, Arbelaiz A, Milkiewicz P, Muntané J, Muñoz-Bellvis L, La Casta A, Gonzalez LM, Arretxe E, Alonso C, Martínez-Arranz I, Lapitz A, Santos-Laso A, Avila MA, Martínez-Chantar ML, Bujanda L, Marin JJG, Sangro B, Macias RIR.

Hepatology. 2019 Aug;70(2):547-562. doi: 10.1002/hep.30319. Epub 2019 Feb 14.

19.

Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib.

Macias RIR, Sánchez-Martín A, Rodríguez-Macías G, Sánchez-Abarca LI, Lozano E, Herraez E, Odero MD, Díez-Martín JL, Marin JJG, Briz O.

Oncotarget. 2018 Jun 19;9(47):28474-28485. doi: 10.18632/oncotarget.25494. eCollection 2018 Jun 19.

20.

Role of the placenta in serum autotaxin elevation during maternal cholestasis.

Macias RIR, Matilla S, Lozano E, Estiú MC, Oude Elferink RP, Marin JJG.

Am J Physiol Gastrointest Liver Physiol. 2018 Sep 1;315(3):G399-G407. doi: 10.1152/ajpgi.00112.2018. Epub 2018 Jun 21.

Supplemental Content

Loading ...
Support Center